107 related articles for article (PubMed ID: 26952843)
1. STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)-STAT3 pathway.
Belton A; Xian L; Huso T; Koo M; Luo LZ; Turkson J; Page BD; Gunning PT; Liu G; Huso DL; Resar LM
Leuk Lymphoma; 2016 Nov; 57(11):2681-4. PubMed ID: 26952843
[No Abstract] [Full Text] [Related]
2. The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?
Hillion J; Dhara S; Sumter TF; Mukherjee M; Di Cello F; Belton A; Turkson J; Jaganathan S; Cheng L; Ye Z; Jove R; Aplan P; Lin YW; Wertzler K; Reeves R; Elbahlouh O; Kowalski J; Bhattacharya R; Resar LM
Cancer Res; 2008 Dec; 68(24):10121-7. PubMed ID: 19074878
[TBL] [Abstract][Full Text] [Related]
3. Clonal origins of ETV6-RUNX1⁺ acute lymphoblastic leukemia: studies in monozygotic twins.
Alpar D; Wren D; Ermini L; Mansur MB; van Delft FW; Bateman CM; Titley I; Kearney L; Szczepanski T; Gonzalez D; Ford AM; Potter NE; Greaves M
Leukemia; 2015 Apr; 29(4):839-46. PubMed ID: 25388957
[TBL] [Abstract][Full Text] [Related]
4. Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia.
Yuan N; Song L; Zhang S; Lin W; Cao Y; Xu F; Fang Y; Wang Z; Zhang H; Li X; Wang Z; Cai J; Wang J; Zhang Y; Mao X; Zhao W; Hu S; Chen S; Wang J
Haematologica; 2015 Mar; 100(3):345-56. PubMed ID: 25512644
[TBL] [Abstract][Full Text] [Related]
5. Immature B-cell progenitors survive oncogenic stress and efficiently initiate Ph+ B-acute lymphoblastic leukemia.
Signer RA; Montecino-Rodriguez E; Witte ON; Dorshkind K
Blood; 2010 Oct; 116(14):2522-30. PubMed ID: 20562326
[TBL] [Abstract][Full Text] [Related]
6. BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.
Slone WL; Moses BS; Hare I; Evans R; Piktel D; Gibson LF
Oncotarget; 2016 Apr; 7(17):23439-53. PubMed ID: 27015556
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression.
Kasai S; Furuichi Y; Ando N; Kagami K; Abe M; Nakane T; Goi K; Inukai T; Saitoh S; Ohno S; Okazaki S; Nagano O; Saya H; Sugita K
Cell Death Dis; 2017 Jun; 8(6):e2857. PubMed ID: 28569787
[TBL] [Abstract][Full Text] [Related]
8. MondoA is highly overexpressed in acute lymphoblastic leukemia cells and modulates their metabolism, differentiation and survival.
Wernicke CM; Richter GH; Beinvogl BC; Plehm S; Schlitter AM; Bandapalli OR; Prazeres da Costa O; Hattenhorst UE; Volkmer I; Staege MS; Esposito I; Burdach S; Grunewald TG
Leuk Res; 2012 Sep; 36(9):1185-92. PubMed ID: 22748921
[TBL] [Abstract][Full Text] [Related]
9. Hmga1 is differentially expressed and mediates silencing of the CD4/CD8 loci in T cell lineages and leukemic cells.
Xi Y; Watanabe S; Hino Y; Sakamoto C; Nakatsu Y; Okada S; Nakao M
Cancer Sci; 2012 Mar; 103(3):439-47. PubMed ID: 22106824
[TBL] [Abstract][Full Text] [Related]
10. Philadelphia Chromosome in an Infant With Pro-B Acute Lymphoblastic Leukemia.
Das A; Bansal D; Sreedharanunni S; Naseem S
J Pediatr Hematol Oncol; 2017 Jan; 39(1):79-80. PubMed ID: 27820127
[No Abstract] [Full Text] [Related]
11. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
[TBL] [Abstract][Full Text] [Related]
13. Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells.
Chen S; Xing H; Li S; Yu J; Li H; Liu S; Tian Z; Tang K; Rao Q; Wang M; Wang J
Leuk Res; 2015 Sep; 39(9):976-83. PubMed ID: 26159495
[TBL] [Abstract][Full Text] [Related]
14. Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcoma.
Wang X; Goldstein D; Crowe PJ; Yang M; Garrett K; Zeps N; Yang JL
Oncotarget; 2016 Apr; 7(16):21496-509. PubMed ID: 26909593
[TBL] [Abstract][Full Text] [Related]
15. Sensitization to Drug Treatment in Precursor B-Cell Acute Lymphoblastic Leukemia Is Not Achieved by Stromal NF-κB Inhibition of Cell Adhesion but by Stromal PKC-Dependent Inhibition of ABC Transporters Activity.
Ruiz-Aparicio PF; Uribe GI; Linares-Ballesteros A; Vernot JP
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500796
[TBL] [Abstract][Full Text] [Related]
16. Rationale for targeting the pre-B-cell receptor signaling pathway in acute lymphoblastic leukemia.
Müschen M
Blood; 2015 Jun; 125(24):3688-93. PubMed ID: 25878119
[TBL] [Abstract][Full Text] [Related]
17. Bioimaging analysis of nuclear factor-κB activity in Philadelphia chromosome-positive acute lymphoblastic leukemia cells reveals its synergistic upregulation by tumor necrosis factor-α-stimulated changes to the microenvironment.
Tsai HJ; Kobayashi S; Izawa K; Ishida T; Watanabe T; Umezawa K; Lin SF; Tojo A
Cancer Sci; 2011 Nov; 102(11):2014-21. PubMed ID: 21777350
[TBL] [Abstract][Full Text] [Related]
18. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
[TBL] [Abstract][Full Text] [Related]
19. Decitabine enhances chemosensitivity of early T-cell precursor-acute lymphoblastic leukemia cell lines and patient-derived samples.
Lu BY; Thanawala SU; Zochowski KC; Burke MJ; Carroll WL; Bhatla T
Leuk Lymphoma; 2016 Aug; 57(8):1938-41. PubMed ID: 26726842
[No Abstract] [Full Text] [Related]
20. LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy.
Zuo M; Li C; Lin J; Javle M
Oncotarget; 2015 May; 6(13):10940-9. PubMed ID: 25883212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]